Lee, Y.-Z.; Hsu, H.-Y.; Yang, C.-W.; Lin, Y.-L.; Chang, S.-Y.; Yang, R.-B.; Liang, J.-J.; Chao, T.-L.; Liao, C.-C.; Kao, H.-C.;
et al. Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics 2023, 15, 342.
https://doi.org/10.3390/pharmaceutics15020342
AMA Style
Lee Y-Z, Hsu H-Y, Yang C-W, Lin Y-L, Chang S-Y, Yang R-B, Liang J-J, Chao T-L, Liao C-C, Kao H-C,
et al. Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics. 2023; 15(2):342.
https://doi.org/10.3390/pharmaceutics15020342
Chicago/Turabian Style
Lee, Yue-Zhi, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao,
and et al. 2023. "Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511" Pharmaceutics 15, no. 2: 342.
https://doi.org/10.3390/pharmaceutics15020342
APA Style
Lee, Y. -Z., Hsu, H. -Y., Yang, C. -W., Lin, Y. -L., Chang, S. -Y., Yang, R. -B., Liang, J. -J., Chao, T. -L., Liao, C. -C., Kao, H. -C., Chang, J. -Y., Sytwu, H. -K., Chen, C. -T., & Lee, S. -J.
(2023). Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics, 15(2), 342.
https://doi.org/10.3390/pharmaceutics15020342
